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Abstract
Therapeutic advances have resulted in an epidemiological shift in the predominant causes of hospitalization
for patients with HIV/AIDS. An emerging cause for hospitalization in this patient population is cardiovascular
disease (CVD); however, data are limited regarding how this shift affects different racial groups. The objective of
this observational, retrospective study was to evaluate the association between race and hospitalization for CVD
in African Americans and whites with HIV/AIDS and to compare the types of CVD-related hospitalizations
between African Americans and whites with HIV/AIDS. Approximately 1.5 million hospital discharges from the
US National Hospital Discharge Surveys for the years of 1996 to 2008 were identified. After controlling for
potential confounders, the odds of CVD-related hospitalization in patients with HIV/AIDS were 45% higher for
African Americans than whites (odds ratio [OR] = 1.45, 95% CI, 1.39–1.51). Other covariates that were associated
with increased odds of hospitalization for CVD included chronic kidney disease (OR = 1.43, 95% CI, 1.36–1.51),
age ‡ 50 years (OR = 3.22, 95% CI, 2.94–3.54), region in the Southern United States (OR = 1.17, 95% CI, 1.11–1.23),
and Medicare insurance coverage (OR = 1.71, 95% CI, 1.60–1.83). Male sex was not significantly associated with
the study outcome (OR = 0.99, 95% CI, 0.96–1.02). Compared to whites with HIV/AIDS, African Americans with
HIV/AIDS had more hospitalizations for heart failure and hypertension, but fewer hospitalizations for stroke
and coronary heart disease. In conclusion, African Americans with HIV/AIDS have increased odds of CVD-
related hospitalization as compared to whites with HIV/AIDS. Furthermore, the most common types of CVD-
related hospitalizations differ significantly in African Americans and whites. (Population Health Management
2013;16:201–207)
Introduction
Despite the many advances in HIV/AIDS care over theyears, African Americans in the United States continue
to account for the majority of HIV/AIDS-related hospitali-
zations. In fact, African Americans are hospitalized more
often than any other race or ethnicity with HIV/AIDS.1,2 The
rates of HIV/AIDS-related hospitalizations have markedly
decreased since the introduction of highly active antiretroviral
therapy (HAART) several years ago.1,3 HAART has resulted
in an epidemiological shift in the predominant causes of
hospitalization; studies have documented a trend toward
non-AIDS defining chronic illnesses, including cardiovascular
disease (CVD), as an increasing cause for hospitalization for
HIV/AIDS patients.1,3 However, data are limited regarding
how this change has impacted the African American HIV/
AIDS community. This study evaluated the relationship be-
tween race and CVD-related hospitalization among African
Americans and whites with HIV/AIDS. This study also
compared the types of CVD-related hospitalizations between
African Americans and whites with and without HIV/AIDS.
Methods
Data source
This was an observational, retrospective comparison of
hospital discharges by African Americans and whites with
and without HIV/AIDS. Data were retrieved from the
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United States National Hospital Discharge Surveys (NHDS)
for the years of 1996 to 2008. These are publicly available,
national, probability sample surveys that have been admin-
istered annually by the Centers for Disease Control and
Prevention since 1965.4 These surveys collect data from
nonfederal acute care hospitals (institutions with an average
length of stay < 30 days) to characterize inpatients dis-
charged from such facilities. These data have been used
previously to characterize CVD-related hospitalizations.5–7
Study design
The Office of the Institutional Review Board at the
University of Texas Health Science Center determined
that this study did not involve human subjects research;
therefore, approval was not necessary. This study en-
compassed discharges by African Americans and whites
between 1996 and 2008. The primary outcome of interest was
the rate of CVD-related hospitalization in African Americans
and whites with HIV/AIDS. CVD-related hospitalizations
were defined as having 1 of the following International
Classification of Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM) codes in the principal discharge position: 401–
404 (hypertension), 410–414, 429.2 (coronary heart disease
[CHD]), 428 (heart failure), or 430–438 (stroke). These CVD
diagnosis codes mimic those used by the American Heart
Association (AHA).8 Any non-CVD ICD-9-CM code in the
principal position was classified as a non-CVD-related hos-
pitalization. Codes 042–044, V08, or 079.53 in any of the 6
remaining diagnosis fields were used to denote HIV/AIDS
diagnosis. Patients < 15 years of age at time of hospitaliza-
tion and those of non-African American or nonwhite race
were excluded from the study. Hospitalizations lasting < 24
hours also were excluded, as these may have been more
representative of emergency care.
Data analysis
All data were analyzed using JMP 8.0 (SAS Institute Inc.,
Cary, NC). A prespecified, 2-tailed alpha level of 0.05 was
used to determine statistical significance. Patient discharge
weights were incorporated to generate nationally represen-
tative estimates. Annual noninstitutionalized civilian popu-
lation estimates for persons ‡ 15 years of age were retrieved
from the US Census Bureau to generate population-based
incidence rates for discharges. Chi-square tests were used for
bivariable analysis of categorical data. A binomial logistic
regression model was constructed to identify independent
risk factors for CVD-related hospitalization. Independent
variables included race, year of hospitalization, age, sex,
geographic region, insurance status, and presence of chronic
kidney disease (CKD). After fitting the main effects model,
tests for statistical interactions were then conducted entering
interaction terms simultaneously in a backward stepwise
regression. Nonstatistically significant or unstable terms
were removed.
Results
Hospitalization rates by race in patients
with and without HIV/AIDS
Between 1996 and 2008, an estimated 1.5 million hospital
discharges occurred in African Americans and whites with
HIV/AIDS, and an estimated 288 million hospital discharges
occurred in African Americans and whites without HIV/
AIDS. The incidence rate for HIV/AIDS discharges in
African Americans was 34.5 per 10,000 population in 1996
and decreased to 26.7 per 10,000 population by 2008 (Fig. 1a);
the rate of decline varied from year to year. For whites, the
incidence rate for HIV/AIDS discharges in 1996 was 4.2 per
10,000 population and decreased to 1.7 per 10,000 population
by 2008.
The incidence rate for non-HIV/AIDS discharges in
African Americans was 1318 per 10,000 population in 1996
and increased to 1503 per 10,000 population by 2008
(Fig. 1b). For whites, the incidence rate for non-HIV/AIDS
discharges in 1996 was 1050 per 10,000 population and de-
creased to 992 per 10,000 population by 2008. The prevalence
of primary CVD diagnosis for HIV/AIDS discharges was
4% in African Americans and 2% in whites, whereas the
prevalence of primary CVD diagnosis for non-HIV/AIDS
discharges was 15% for both African Americans and whites.
Risk factors associated with CVD-related
hospitalization in patients with HIV/AIDS
In the binomial regression model, the odds of CVD-related
hospitalization in patients with HIV/AIDS were 45% higher
for African Americans than for whites (Table 1). The pres-
ence of CKD was also a significant risk factor for CVD-
related hospitalization. Other variables that were associated
with increased odds of hospitalization for CVD included
FIG. 1. Population-based incidence of hospital discharges
from 1996–2008 for (A) African Americans and whites with
HIV/AIDS and (B) African Americans and whites without
HIV/AIDS.
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older age ( ‡ 50 years), region in the Southern United States,
and Medicaid and Medicare insurance coverage (Table 1).
Male sex was not significantly associated with CVD-related
hospitalization. After fitting the main effects model, the
following interaction terms remained statistically significant:
race*sex, race*geographic region, and race*insurance status
( P < 0.001). However, the odds of CVD-related hospitaliza-
tion were still greater for African Americans than for whites
(odds ratio = 1.96, 95% CI, 1.77–2.17).
Comparison of selected baseline demographics
in patients with HIV/AIDS by race
Demographic variables that differed significantly between
African Americans and whites with HIV/AIDS included:
age, sex, geographic region, insurance status, and CKD (all
P < 0.001) (Table 2). The small differences in age categories
are likely of limited practical significance. Of note, a greater
proportion of African Americans were female as compared
to whites. A greater proportion of African Americans than
whites resided in the Southern and Northeast United States,
while a smaller proportion of African Americans than
whites resided in the West. A smaller proportion of African
Americans than whites possessed private insurance and
Medicaid insurance, while a greater proportion had Medi-
care coverage. Lastly, CKD diagnosis was more common in
African Americans than in whites.
Racial comparison of the types of CVD-related
hospitalizations by HIV/AIDS status
Significant associations were observed for CVD type in
both African Americans and whites by HIV/AIDS status
(Fig. 2). Compared to African Americans without HIV/
AIDS, African Americans with HIV/AIDS had greater
proportions of heart failure and hypertension, but lower
proportions of stroke and CHD (x2 = 359.94; df = 3; P < 0.001).
Whites with HIV/AIDS had slightly greater proportions of
Table 1. Logistic Regression Analysis for Risk Factors Associated
with CVD-Related Hospitalization Among African Americans and Whites with HIV/AIDS
Variable b Standard Error Wald Chi-Sq P Value OR 95% CI
Intercept - 3.92 0.06 4507.79 < 0.001 0.02 -
Race
(White referent) - - - - - -
African American 0.37 0.02 314.10 < 0.001 1.45 (1.39–1.51)
Sex
(Female referent) - - - - - -
Male - 0.01 0.02 0.35 0.56 0.99 (0.96–1.02)
Age (y)
(15–29 referent) - - 1070.86 < 0.001 - -
30–49 0.16 0.05 11.96 < 0.001 1.18 (1.07–1.29)
‡ 50 1.17 0.05 595.75 < 0.001 3.22 (2.94–3.54)
Geographic region
(Northeast referent) - - 46.46 < 0.001 - -
Midwest - 0.10 0.05 4.21 0.04 0.91 (0.83–1.00)
West 0.02 0.04 0.33 0.57 1.02 (0.94–1.11)
South 0.16 0.03 33.17 < 0.001 1.17 (1.11–1.23)
Insurance status
(Private referent) - - 288.21 < 0.001 - -
Uninsured - 0.59 0.07 66.05 < 0.001 0.56 (0.48–0.64)
Medicaid 0.26 0.03 58.20 < 0.001 1.29 (1.21–1.38)
Medicare 0.54 0.04 232.24 < 0.001 1.71 (1.60–1.83)
Other/unknown - 0.62 0.07 72.83 < 0.001 0.54 (0.47–0.62)
Year
(1996 referent) - - 276.16 < 0.001 - -
1997 - 0.40 0.07 29.44 < 0.001 0.67 (0.58–0.77)
1998 0.10 0.06 3.24 0.07 1.11 (0.99–1.24)
1999 - 0.08 0.07 1.55 0.21 0.92 (0.81–1.05)
2000 0.00 0.06 0.00 0.97 1.00 (0.89–1.13)
2001 0.19 0.05 12.26 < 0.001 1.21 (1.09–1.34)
2002 - 0.07 0.06 1.22 0.27 0.93 (0.83–1.06)
2003 0.53 0.05 125.98 < 0.001 1.71 (1.55–1.87)
2004 - 0.06 0.06 1.14 0.29 0.94 (0.84–1.05)
2005 0.12 0.06 4.25 0.04 1.12 (1.01–1.26)
2006 0.36 0.06 62.68 < 0.001 1.44 (1.31–1.57)
2007 - 0.35 0.06 34.49 < 0.001 0.71 (0.63–0.79)
2008 - 0.31 0.06 27.83 < 0.001 0.74 (0.66–0.82)
CKD
(No CKD referent) - - - - - -
CKD 0.36 0.03 180.22 < 0.001 1.43 (1.36–1.51)
R2(U) = 0.0747; Ch-sq = 2610.08; P < 0.001.
CKD, chronic kidney disease; CVD, cardiovascular disease; OR, odds ratio.
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heart failure and stroke, but slightly lower proportions of
CHD and hypertension than whites without HIV/AIDS
(x2 = 13.18; df = 3; P < 0.001). A post hoc subgroup analysis of
the African American cohort of patients ‡ 50 years of age at
time of hospitalization was conducted to assess the magni-
tude of difference for CVD type; similar relationships were
seen for the older cohort, but the differences were less pro-
nounced (x2 = 27.24; df = 3; P < 0.001).
Racial comparison of the types of CVD-related
hospitalizations in patients with HIV/AIDS by sex
Similar trends in CVD type between the 2 sexes were
noted in both races, in that CHD and heart failure were
greater in males than in females (Fig. 3). In contrast, hyper-
tension and stroke were greater in females than in males. The
association between CVD type and sex was statistically sig-
nificant for African Americans with HIV/AIDS (x2 = 339.05;
df = 3; P < 0.001) as well as for whites with HIV/AIDS
(x2 = 68.99; df = 3; P < 0.001).
Discussion
This study investigated the relationships between race,
HIV/AIDS, and hospitalizations for CVD and, thus, adds to
the limited body of knowledge in this area. Pertinent find-
ings are that race appears to influence the occurrence and
type of CVD-related hospitalization in HIV/AIDS patients.
There also appears to be a sex–race interaction for the
various conditions; men with HIV/AIDS had greater
proportions of heart failure and CHD but lower proportions
of hypertension and stroke as compared to their female
counterparts.
The present findings, that CVD-related hospitalizations in
patients with HIV/AIDS were greater for African Americans
Table 2. Comparison of Selected Demographics
between Hospitalized African Americans






(n = 540,446) P Value
Age (y), % - - < 0.001
15–29 8.5% 7.4% -
30–49 72.1% 72.3% -
‡ 50 19.4% 20.3% -
Sex, % - - < 0.001
Male 60.4% 79.7% -
Female 39.6% 20.3% -
Geographic region, % - - < 0.001
Northeast 30.3% 25.5% -
Midwest 9.6% 8.3% -
West 6.2% 28.0% -
South 53.9% 38.3% -
Insurance status, % - - < 0.001
Private 14.0% 27.5% -
Uninsured 9.5% 8.1% -
Medicare 46.1% 32.2% -
Medicaid 21.9% 26.0% -
Other/unknown 8.5% 6.2% -
Chronic kidney
disease, %
- - < 0.001
Yes 6.8% 2.0% -
No 93.2% 98.0% -
FIG. 2. Types of cardiovascular disease (CVD)-related
hospitalizations in (A) African Americans with and without
HIV/AIDS and (B) whites with and without HIV/AIDS.
FIG. 3. Types of cardiovascular disease (CVD)-related
hospitalization by sex in (A) African Americans with HIV/
AIDS and (B) whites with HIV/AIDS.
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than for whites, have been reported previously.1,9 However,
other studies have not detected such disparities. For exam-
ple, it has been purported that presentation with lower
CD4 + and the development of AIDS, rather than race, are
predictive of cardiac events.10 It has been demonstrated that
African Americans with HIV/AIDS tend to have more
progressive disease and lower CD4 + than other races.11,12
Although these variables were not available for evaluation in
the present study, the results of this investigation may help
to explain the association of African American race with a
higher likelihood of CVD-related hospitalization.
Other factors that were significantly associated with an
increase in CVD-related hospitalization included older age,
CKD, Southern region, and Medicaid and Medicare cover-
age. The associations for age and CKD were expected, as
both are associated with an increased risk for the develop-
ment of CVD in the general population.8 The association for
Medicare insurance might be explained by the fact that
Medicare provides coverage largely to adults older than
65 years of age, which likely coincides with the age associa-
tion. Medicaid coverage might be explained by the fact
that Medicaid recipients with HIV/AIDS have been reported
to have a high prevalence of comorbidities.13 These co-
morbid conditions may place patients with HIV/AIDS at
greater risk for CVD diagnosis and subsequent CVD-related
hospitalizations. The association between the Southern region
and CVD-related hospitalizations may denote the high prev-
alence of obesity in the South; obesity is a risk factor for heart
disease and is on the rise in the African American population.14
It is worthwhile to note some of the racial demographic
differences in patients with HIV/AIDS. Geographic varia-
tions, in that African Americans with HIV/AIDS are more
likely to reside in the South, are supported by national sur-
veillance data.15,16 This work also provides support for a
possible sex–race interaction for HIV/AIDS and CVD as the
burden of disease type varied greatly by race and by sex.
African American females were overly represented as com-
pared to white females, a disparity that has been well
documented.5,15,16 Insurance coverage varied greatly be-
tween African Americans and whites. Medicaid coverage
was reported in nearly half of all African Americans as
compared to one third of whites. Patients can qualify for
Medicare insurance if they are: older than 65 years of age,
have a qualifying disability, or have end-stage renal dis-
ease.17 The higher prevalence of CKD in African Americans
might help explain the greater proportion of Medicare as
such associations have been demonstrated.18–20 Although the
prevalence of CKD in the general population is greater in
African Americans than in whites, the prevalence of CKD
between the 2 races in this study was 2-fold greater for African
Americans with HIV than for African Americans without
HIV. It is possible that race alone does not explain the
observed differences in CKD. Further research should explore
how HIV/AIDS status is differentially associated with CKD
development in African Americans as compared to whites.
The present study also included a comparison of the
different types of CVD in the 2 HIV/AIDS race cohorts. Of
the 4 types of CVD in this study, CHD has the highest
mortality rate and is associated with the highest health care-
related costs. CHD is the leading cause of death in the United
States, accounting for approximately 1 of every 6 deaths.21,22
The prevalence of CHD in the general population for the 4
subgroups is somewhat similar. As of 2006, the disease
prevalence was 9.4% among white males, 8.8% among
African American females, 7.8% among African American
males, and 6.9% among white females.23 This study revealed
that the highest proportion of disease was CHD in whites
with HIV/AIDS, particularly in males. This coincides with
national prevalence data; the greatest proportion of CHD is
in white males. Disease burden is next greatest for African
American females, yet this study revealed that African
American females with HIV/AIDS had the lowest propor-
tion of CHD-related hospitalizations.
It is likely that African Americans with HIV/AIDS and
CHD were underrepresented in this study. This may espe-
cially be the case for African American females, the subgroup
with the lowest prevalence of CHD-related hospitalizations.
Because of the study design, out-of-hospital cardiac events
were not captured. African Americans have been shown to
have nearly double the incidence of out-of-hospital cardiac
events than whites, namely cardiac arrest, at an age-adjusted
incidence of 10.1 per 10,000 adults compared to a rate of 5.8
per 10,000 adults.24 Cardiac arrest does not necessarily imply
CHD, but CHD is a risk factor for cardiac arrest. Moreover, it
is estimated that approximately 250,000 deaths occur each
year from sudden cardiac death prior to hospitalization,
most frequently in African American men.25 Similarly, it has
been documented that African Americans are less likely than
whites to be hospitalized for cardiac-related procedures and
are less likely to be admitted to cardiac hospitals.26 These
findings underscore the need to ensure that all patients with
HIV/AIDS have adequate access to primary care and pre-
ventive health services in order to reduce the occurrence of
cardiac events.
Similar to CHD, the prevalence of stroke in the general
population is quite similar across the 4 subgroups: African
American females (4.3%), African American males (3.8%),
white females (3.1%), and white males (2.3%).23 Stroke is
typically more common in women than in men. However,
this study revealed an absolute difference between the sexes
that was more pronounced in whites with HIV/AIDS than in
African Americans with HIV/AIDS; the greatest proportion
of stroke was noted in white females. A plausible explana-
tion for this finding could be failure to recognize stroke
symptoms in African American females, leading to de-
creased hospitalizations for stroke.27 If African American
females lack timely recognition of stroke symptoms, they
may experience more out-of-hospital events, including
mortality. These results reiterate the need for adequate car-
diac preventive services for all HIV/AIDS patients in the
ambulatory care setting.
Hypertension is a risk factor for other forms of CVD.8 The
prevalence of this disease is more disparate for African
Americans than for any other race. Worldwide, African
Americans retain the highest prevalence of hypertension; a
rising statistic, especially for females.28 As of 2006, the
prevalence of hypertension was 44.8% among African
American females, 43.0% among African American males,
31.1% among white females, and 34.3% among white
males.23 The proportion of hypertension-related hospitali-
zation was greatest in African American women. African
Americans tend to have higher blood pressure readings and
develop the disease at relatively younger ages compared to
whites.29 A study of hypertensive patients from 28 physician
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practices nationwide revealed that the odds of blood pres-
sure control were over 50% lower in African Americans than
in whites.29 Mortality attributed to hypertension also varies
by subgroup. According to 2006 national vital statistical
data, the rate of mortality (per 100,000 population) was 51.1
in African American males, 37.3 in African American fe-
males, 15.6 in white males, and 14.3 in white females.21 As
the incidence of HIV infection is on the rise in the young
African American population, and hypertension develops in
African Americans at younger ages and can lead to other
forms of CVD, there is growing cause for concern about CVD
in African Americans with HIV/AIDS.
Heart failure was least common compared to the other
forms of CVD. Of all the types of CVD in this study, the least
amount of disease discordance was noted for heart failure,
implying that the concern for race- and sex-based disparities
for HIV/AIDS and heart failure may not be as great when
compared to the other conditions.
Race also appears to have an influence on HIV/AIDS
status and CVD type. The greatest magnitude of difference
across all CVD types was 12% in African Americans (CHD)
compared to 3% in whites (CHD and stroke). Per post hoc
subgroup analysis of the older African American cohort, the
magnitude of disease difference for those with HIV/AIDS
and those without HIV/AIDS was still most pronounced for
CHD (9%). Earlier, it was discussed that African Americans
with cardiac arrest may be less likely to receive care in the
hospital setting, leading to possible underrepresentation
in this study. This is especially concerning for African
Americans with HIV/AIDS who have a CHD diagnosis. This
unexpected disparity warrants further investigation.
This study was subject to limitations that were primarily
related to the nature of the design of the NHDS. All diag-
noses were based on coding of up to 7 discharge diagnoses.
Determining preexisting conditions and timing of diagnoses
was not possible. Medication histories were not available
within the NHDS, which precluded evaluating the relation-
ship between long-term HAART exposure and the devel-
opment of CVD. All data were presented in terms of hospital
discharges based on weighted estimates rather than in terms
of individual patients. The study was a compilation of cross-
sectional data over 13 years, rather than a longitudinal study
following the same cohort of patients over a period of time.
Information for Hispanic patients was not included, as eth-
nicity is not collected in these surveys. Lastly, the sample of
hospitals included in the NHDS may have changed from
year to year, which ultimately may have affected the popu-
lation of patient discharges that were included in each year.
Despite these limitations, this study has advantages com-
pared to prior studies. The present study was long in dura-
tion and had a large sample size. CVD was based on the
AHA definition and ICD-9-CM codes were used to denote
primary diagnoses. This study compared differences in CVD-
related hospitalizations by race, sex, and HIV/AIDS status to
provide some insight into this complex interaction. The data
add to the limited body of literature that pertains to racial
and sex-related disparities in CVD-related hospitalizations.
Conclusion
The study sought to explore the relationship between
race, HIV/AIDS, and CVD in an acute care setting. The
findings suggest that African Americans with HIV/AIDS
have increased odds of CVD-related hospitalization as
compared to whites with HIV/AIDS, and the most com-
mon types of CVD-related hospitalization differed sig-
nificantly by race. There also appears to be a sex–race
interaction of CVD type that merits further investigation.
These findings underscore the need to ensure that patients
with HIV/AIDS, particularly minority patients, have ade-
quate access to primary care and preventive cardiac health
services in order to reduce the occurrence of CVD-related
hospitalizations.
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